Morgan Stanley analyst Kristine Liwag reiterated a Buy rating on Northrop Grumman today and set a price target of $625.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kristine Liwag has given her Buy rating due to a combination of factors that highlight Northrop Grumman’s strong position in the defense sector. The company is benefiting from increased funding for key programs such as the B-21 Raider and E-2D, which underscores its strategic importance to the Department of Defense. This funding boost not only enhances the economic prospects of these programs but also shifts market sentiment positively after previous challenges.
Additionally, Northrop Grumman’s international expansion is outpacing overall portfolio growth, positioning it well for opportunities in integrated air and missile defense and weapons systems in Europe and the Middle East. The company’s ability to capitalize on accelerating global defense spending further supports the positive outlook. As a result, Kristine Liwag has moved Northrop Grumman to her top defense pick and increased the price target to $625, reflecting the favorable risk-reward balance.
In another report released on July 16, RBC Capital also maintained a Buy rating on the stock with a $600.00 price target.